CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
Calcium channels blockers – group of the drugs which basic property is ability to brake a calcium current inside of smooth muscle cells through the special channels named “slow calcium channels”. Diltiazem Lannacher renders cardioprotective action with antioxidative effect, angioprotective action, antiagregant action, antiatherogenous action, nephroprotective action, cerebroprotective action.
Л.К. Каражанова, д.м.н., профессор
А.А. Чиныбаева
Государственный медицинский университет города Семей
1. Fleckenstein A., Tritthart H., Fleckenstein B., Herbst A., Grun G. Eine neue Gruppe kompetitiver Ca++ -Antagonisten (Iproveratril, D6000, Prenylamin) mit starken Hemeffekten auf die elektromekanische Koppelung im Warmbluter-myocard // Pflugers Arch 1969: 307: R25.
2. Deanfield JE, Maseri A, Selwin AP. Myocardial is-chemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 1983;1:753-8.
3. Fleckenstein A., Tritthart H., Fleckenstein B., Herbst A., Grun G. Eine neue Gruppe kompetitiver Ca++ -Antagonisten (Iproveratril, D6000, Prenylamin) mit starken Hemeffekten auf die elektromekanische Koppelung im Warmbluter-myocard // Pflugers Arch 1969: 307: R25.
4. Blood Pressure Lowering Treatment Trialists’ Collab-oration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000;356:1955-64.
5. Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, и др. Lancet. 2000 Jul 29;356(9227):359-65.
6. Pahor M, Psaty BM, Alderman MH et al. Health out-comes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356:1949-54.
7. Steflox HT, Chua G, O’Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. New Engl J Med 1998;338:101-6.
8. Шестакова М.В. Эндокринологический научный центр РАМН, Москва, 2001 Терапевтический архив, 2001г №6
9. Добронравов В.А., Царькова О.В., «Блокаторы кальциевых каналов в нефропротекции», Нефрология 2004, т.8 №1, с.7-21
Number of Views: 276
Category of articles:
Lectures
Bibliography link
Л.К. Каражанова , А.А. Чиныбаева АНТАГОНИСТЫ КАЛЬЦИЯ БЕНЗОТИАЗЕПИНОВОГО РЯДА - РОЛЬ В СОВРЕМЕННОЙ ТЕРАПИИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ: В ФОКУСЕ – ДИЛТИАЗЕМ //НАУКА И ЗДРАВООХРАНЕНИЕ 2012.№ 2. С. 24-32 L.K. Karazhanova, A.A. Chinybayeva CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM. 2012.№ 2. С. 24-32 Л.Қ. Қаражанова, А.А. Чиныбаева ЖҮРЕК – ҚАН ТАМЫР АУРУЛАРЫНЫҢ ҚАЗІРГІ ЗАМАН ТЕРАПИЯСЫНДА КАЛЬЦИЙ АНТАГОНИСТЕРІНІҢ РОЛІ . ФОКУСТА: ДИЛТИАЗЕМ // ҒЫЛЫМ ЖӘНЕ ДЕНСАУЛЫҚ САҚТАУ. 2012.№ 2. С. 24-32Related publications:
PAIN AND INCREASED MUSCLE TONE AFTER A STROKE AS REDUCTION FACTORS FOR REHABILITATION POTENTIAL. A MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF PATIENTS
FEATURES OF VARIOUS NEUROLOGICAL SYSTEMS DYSFUNCTION OF VASCULAR DISEASES OF THE BRAIN
DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (CHF)
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN